Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

BUPIVACAINE AND EPINEP

Active
SPE2DP-26-T-4085Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of Bupivacaine and Epinephrine Injection in a concentration of 0.500% w/v bupivacaine HCl and 0.005 mg epinephrine per milliliter (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one container (CN) containing fifty (50) cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must maintain a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an original 18-month shelf life. Packaging and marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all containers must be sealed and capable of protecting contents from damage. Exterior shipping containers must ensure safe, cost-effective delivery to the designated destination, with palletization following DLA Packaging Requirements. The item is subject to strict hazardous materials guidelines, prohibiting intentional introduction of mercury or mercury-containing compounds unless exempted for specific functional uses, with additional containment requirements for exempted items. Delivery is FOB destination with zero variance permitted in quantity, inspection and acceptance occurring at the destination, and must be completed within five days of contract award. The product is designated as a Type I (Code K) shelf-life item with a non-extendable 18-month shelf life, and the delivery address is a U.S. Navy vessel based in FPO AP 96662. The contract number is SPE2DP-26-T-4085, with a required delivery date of July 14, 2026, and the procurement is managed by the Department of Defense’s Medical Supply Chain Pharmacy Fulfillment Support Activity.

General Info

Bupivacaine and epinephrine injection, 0.500% w/v, 1.8 mL cartridges, 50 per CN, FOB destination, delivery by July 14, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100163 BOX 1, FPO, AP, 96662, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4085 Medical Supply Chain Pharm FSA

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Michelangelo Truscia
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
BUPIVACAINE AND EPINEPHRINE INJECTION
BUPIVACAINE <(>&<)> EPINEPHRINE INJECTION
.
0.500 PCT W/V BUPIVACAINE HCL AND 0.005 MG
EPINEPHRINE/ML (1:200,000) 1.8 ML CARTRIDGE, 50'S
.
UNIT OF ISSUE: (U/I): CN (CAN)
.
CONTROLLED ROOM TEMP OR REQUIRES CONTROLLED ROOM TEMP
STORAGE BETWEEN 15 AND 30 DEG C.
.
SHELF LIFE IS 18 MONTHS. A SHELF LIFE OF 15 MONTHS
SHELF LIFE SHALL REMAIN AT THE TIME OF DELIVERY TO THE
FIRST GOV'T ACTIVITY.
.
MARK IN ACCORDANCE WITH MMS No. 1B 30 March 2017
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
SPE2DP-26-T-4085
SECTION B
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 CN = 50 EA
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
.
FSSB 11/14/2019
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
HENRY SCHEIN, INC. 0NUS8 P/N 1316823 CARESTREAM DENTAL LLC 47R32 P/N 99184 PATTERSON DENTAL 5XLW0 P/N 095-2796 BENCO DENTAL SUPPLY CO. 1V865 P/N 5235-587 DENTAL HEALTH PRODUCTS INCORPORATED 02QR5 P/N 120-99184
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017448212 0001 CN 1.000
NSN/MATERIAL:6505011893973
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129.
SPE2DP-26-T-4085
SECTION B
PR: 7017448212 PRLI: 0001 CONT’D
The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21763
USS CHARLOTTE SSN 766
UNIT 100163 BOX 1
FPO AP 96662
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21763
USS CHARLOTTE SSN 766
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R2176361903069
RDD: 777
PROJ: JP5 TP 2
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A41 DIST: E9B ADV: 2A FC: M7
Need Ship Date:00/00/0000 Original Required Delivery Date:07/14/2026
SPE2DP-26-T-4085 NSN/Part Number: 6505-01-189-3973 Quantity: 1 CN Purchase Request: 7017448212QTY: 1 Delivery: 5 days ADO

Similar Contracts

NAICS: 325412
New
DIBBS
ACYCLOVIR TABLETSACYCLOVIR TABLETS, 800 MG, are being procured under contract SPE2DP-26-T-4088 with a total quantity of 4 bottles, each containing 100 tablets, as defined by the unit of issue BT. The supplier must provide the product in commercial packaging that protects against damage and breakage, with exterior shipping containers suitable for safe delivery by common carriers at the lowest cost to the designated destination. All packaging and marking must comply with Medical Marking Standard No. 1, which replaces MIL-STD-129, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List of Technical and Quality Requirements. The product must bear one of the approved NDC codes: 60429-0713-01, 00093-8947-01, 00173-0945-55, 61442-0113-01, 00378-0302-01, 51407-0146-01, or 60505-5307-01. The item is classified as a TYPE I (CODE M) with a fixed 24-month shelf life that cannot be extended. Mercury or mercury-containing compounds are prohibited unless functionally necessary and compliant with NAVSEA standards, such as in certain instruments or batteries. Delivery is FOB destination within five days of contract award, with no variance permitted in quantity, and inspection and acceptance occur at the point of delivery. The contract is issued by the Department of Defense under NAICS code 325412, with performance location at Fort Bragg, North Carolina, and point of contact at Timothy McCauley for inquiries.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE AND SODIUM CHDextrose and Sodium Chloride Injection USP, provided in sterile, nonpyrogenic, single-dose containers, is intended for intravenous use only and contains 5 grams of hydrous dextrose and 0.45 grams of sodium chloride per 100 mL, with each bag holding 1 liter. The product is latex-free but contains DEHP and must be stored at controlled room temperature between 20 to 25°C, protected from excessive heat and freezing. Each package contains twelve 1-liter bags, and the solution must be visually inspected for clarity and intact seals prior to use. The item is regulated by the FDA with a nonextendable shelf life of 30 months and must be marked in full compliance with Medical Marking Standard No. 1 and MIL-STD-129. Packaging must adhere to DLA’s procurement requirements, with commercial packaging under ASTM D3951 unless otherwise superseded by DLA technical standards. The manufacturer is ICU Medical Sales, Inc., identified by NDC 00990-7926-09. The contract, issued under solicitation SPE2DP-26-T-4076, requires delivery of one box containing twelve 1-liter bags to FPO AP 96692 within 20 days of award, with zero variance allowed in quantity. Delivery is FOB destination, inspected and accepted at the delivery point. The item is assigned NSN 6505-00-116-1025 and is subject to covered defense information requirements. The contract specifies a required delivery date of July 14, 2026, with no alternate ship date provided. All shipments must follow DLA transport protocols and are tied to project JP5 TP 2, with primary point of contact Daniel Porter at the Department of Defense, Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
FLUCONAZOLE TABLETSFluconazole tablets 150 mg are procured in individually sealed blister strips containing 12 tablets per unit, with the unit of issue defined as a package. Each unit must have a minimum shelf life of 24 months from the date of manufacture, and no more than three months may have elapsed between the date of manufacture and delivery to the government. The product must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging and labeling must adhere to commercial standards ensuring protection from damage and safe transportation via common carrier. Mercury and mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, except for specific approved uses such as batteries or instrument components, which must be contained within a secondary boundary and meet NAVSEA 5100-003D requirements. The item is identified by NSN 6505013953039 and is subject to DLA’s Master List of Technical and Quality Requirements, with applicable revisions governed by the solicitation or award date. Deliveries must be made FOB destination within 20 days, with no tolerance for quantity variance. Inspection and acceptance occur at the point of delivery, and pre-delivery packaging must conform to MIL-STD-2073-1E. The contract is issued under solicitation SPE2DP-26-T-4081, with a response deadline of July 20, 2026, and is managed by the Department of Defense’s Medical Supply Chain PFS. The manufacturer is identified by NDC codes from Golden State Medical Supply Inc. and ANIP Acquisition Co.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, containing 7.5% active ingredient, is specified for external use only and must be delivered in 1-gallon bottles with a unit of issue designated as BT. The product requires a minimum of 31 months of remaining shelf life upon delivery to the first government activity, with a total shelf life of 36 months, non-extendable, and must be stored at 25°C (77°F) with allowable excursions between 15°C and 30°C (59°F–86°F). Packaging must comply with DLA’s Packaging Requirements for Procurement and Medical Marking Standard No. 1, superseding MIL-STD-129, and all containers must be commercially sealed to prevent damage during transit. The product is classified as hazardous under Federal Standard No. 313-E, requiring submission of updated Safety Data Sheets and HCS-compliant labels aligned with OSHA’s Globally Harmonized System, along with employee training on these requirements. All shipments must be delivered FOB destination within 20 days, with no variance in quantity permitted, and inspected upon arrival. The item is regulated by the FDA and must be marked, labeled, and palletized according to DLA standards, with transportation directed via traceable means excluding parcel post. Delivery is scheduled for USS ZUMWALT DDG 1000 at FPO AP 96693, with the original required delivery date set for July 14, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile, topical antibiotic product containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use in single-dose tubes of 3.5 grams each. Each unit is packaged as a 24-tube unit, with a total shelf life of 36 months, requiring a minimum of 31 months of remaining shelf life upon delivery to the first government activity. The product must be stored at controlled room temperature between 15°C and 30°C (59°F–86°F), protected from excessive heat and freezing. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adherence to the DLA Master List of Technical and Quality Requirements is mandatory, taking precedence over commercial standards such as ASTM D3951. Packaging must ensure protection from damage and enable safe, cost-effective delivery via common carrier to designated military installations, with shipment required by the fastest traceable means, excluding parcel post. The contract specifies four separate delivery lines totaling eight packages, with shipments directed to Fort Bragg, Fort Lewis, Fort Campbell, and additional Fort Bragg locations. Each delivery line has a five-day delivery window, FOB destination, and no quantity variance allowed. The item’s NSN is 6505011897090, and the manufacturer is PADAGIS US LLC with NDC 00574-4024-39. The product is regulated by the FDA, and buyers must route referrals through EBS for confirmation. All units must be palletized according to DLA packaging standards and clearly marked in accordance with the specified medical marking protocol. The solicitation number is SPE2DP-26-T-4083, with a required delivery date of July 14, 2026, and the contracting official is James McCullough of the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details